Jayson D. Wilbur, Ph.D.

Principal Scientist I

Jayson is an experienced statistician who joined Metrum after working for several years on problems in diagnostic medicine and public health in both industrial and academic settings. Since joining Metrum, Jayson’s work has focussed on problems in oncology and global health and methods for longitudinal and functional data, machine learning and causal inference.

Recent publications by this scientist

Phase 1 study to evaluate the effect of the investigational anticancer agent sapanisertib on the QTc interval in patients with advanced solid tumors

June 1, 2020

Patel, Chirag, Sanjay Goel, Manish R. Patel, Lakshmi Rangachari, Jayson D. Wilbur, Yaping Shou, Karthik Venkatakrishnan, and A. Craig Lockhart. Clinical Pharmacology in Drug Development, June 2020.

View More

Simplified models to assess gestational age in low-middle income countries: Findings from the multi-site AMANHI study

May 1, 2020

A.C. Lee, K.E. Semrau, B. Wylie, A.H. Baqui, B. Kirkwood, A.A. Manu, F. Jehan, M. Nisar, S. Sazawal, U. Dhingra, D.H. Hamer, J.D. Wilbur, S. Yoshida, R. Bahl.  Simplified Models to Assess Gestational Age in Low-Middle Income Countries: Findings from the Multi-site AMANHI Study.  Pediatric Academic Societies Meeting, May 2, 2020. E-PAS2020:1555.6

View More

Vedolizumab exposure levels and clinical outcomes in ulcerative colitis: determining the potential for dose optimisation

January 29, 2019

Osterman MT, Rosario M, Lasch K, Barocas M, Wilbur JD, Dirks NL, Gastonguay MR. Aliment Pharmacol Ther. 49(4):408–18. February 2019.

View More